Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-07-22 1:34 pm Sale | 13D | Seres Therapeutics Inc. MCRB | Nestle Health Science US Holdings Inc. | 7,594,038 6.100% | -298,852 (-3.79%) | View |
| 2022-02-14 10:20 am Purchase | 13G | PROMETHEUS BIOSCIENCES INC RXDX | Nestle Health Science US Holdings Inc. | 3,730,841 9.580% | 3,730,841 (New Position) | View |
| 2020-09-09 8:00 pm Unchanged | 13G | AXCELLA HEALTH INC AXLA | Nestle Health Science US Holdings Inc. | 4,305,541 11.810% | 0 (Unchanged) | View |
| 2020-08-19 5:17 pm Purchase | 13D | Seres Therapeutics Inc. MCRB | Nestle Health Science US Holdings Inc. | 7,892,890 8.800% | 993,689 (+14.40%) | View |
| 2020-05-21 5:01 pm Purchase | 13G | AXCELLA HEALTH INC AXLA | Nestle Health Science US Holdings Inc. | 4,305,541 12.000% | 1,936,842 (+81.77%) | View |
| 2020-04-24 4:30 pm Unchanged | 13D | Aimmune Therapeutics Inc. AIMT | Nestle Health Science US Holdings Inc. | 12,727,113 19.600% | 0 (Unchanged) | View |
| 2020-02-13 2:14 pm Purchase | 13G | AXCELLA HEALTH INC AXLA | Nestle Health Science US Holdings Inc. | 2,368,699 10.200% | 2,368,699 (New Position) | View |
| 2020-02-11 11:57 am Purchase | 13D | Aimmune Therapeutics Inc. AIMT | Nestle Health Science US Holdings Inc. | 12,727,113 19.900% | 1,000,000 (+8.53%) | View |